SCHEMBL9609426

SCHEMBL9609426

O=c1c2ccccc2n(Cc2cccc(O)c2)c2ccc([S+](c3cc(F)c(F)c(F)c3)c3cc(F)c(F)c(F)c3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX4 Q99571 4/20 0.45
▸ ALDH1A1 P00352 6/20 0.40
▸ MAPT P10636 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ MAPK10 P53779 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MIF P14174 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ PIM1 P11309 1/20 0.37
▸ HTT P42858 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ RCE1 Q9Y256 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609418 0.90 P2RX4 (0.47) P2RX4ALDH1A1MAPTKDM4EMEN1
SCHEMBL9609422 0.89 P2RX4 (0.58) P2RX4ALDH1A1MAPTKDM4EMEN1
SCHEMBL21365448 0.81 P2RX4 (0.68) P2RX4ALDH1A1MAPTKDM4EMEN1
SCHEMBL9609427 0.81 MAPT (0.42) P2RX4ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL9609417 0.80 P2RX4 (0.61) P2RX4ALDH1A1MAPTKDM4EMEN1
SCHEMBL9609419 0.79 P2RX4 (0.47) P2RX4ALDH1A1MAPTKDM4EMEN1
SCHEMBL9609423 0.79 P2RX4 (0.49) P2RX4ALDH1A1MAPTKDM4EMEN1
SCHEMBL9609404 0.74 KCNA3 (0.43) P2RX4ALDH1A1MAPTMEN1KMT2A
SCHEMBL9609397 0.72 ATM (0.50) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL9609425 0.72 HDAC6 (0.41) P2RX4ALDH1A1MAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073854-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2015-07-07 — — US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 P2RX4 1078/4885ALDH1A1 2040/4885MAPT 1744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback